|
Name |
Trichotetronine
|
| Molecular Formula | C28H32O8 | |
| IUPAC Name* |
(1R,3S,4S,7R,8S)-7-[(2E,4E)-hexa-2,4-dienoyl]-3-hydroxy-8-[(2R)-3-hydroxy-2,4-dimethyl-5-oxofuran-2-yl]-5-[(2E,4E)-1-hydroxyhexa-2,4-dienylidene]-1,3-dimethylbicyclo[2.2.2]octane-2,6-dione
|
|
| SMILES |
C/C=C/C=C/C(=O)[C@@H]1[C@H]([C@H]2C(=C(/C=C/C=C/C)O)C(=O)[C@@]1(C(=O)[C@@]2(C)O)C)[C@@]3(C(=C(C(=O)O3)C)O)C
|
|
| InChI |
InChI=1S/C28H32O8/c1-7-9-11-13-16(29)18-20-21(28(6)22(31)15(3)24(33)36-28)19(17(30)14-12-10-8-2)26(4,23(18)32)25(34)27(20,5)35/h7-14,19-21,29,31,35H,1-6H3/b9-7+,10-8+,13-11+,14-12+,18-16?/t19-,20-,21-,26-,27+,28-/m1/s1
|
|
| InChIKey |
POOKHYNGUAZJAE-XJZPPUTOSA-N
|
|
| Synonyms |
Trichotetronine
|
|
| CAS | NA | |
| PubChem CID | 102329399 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 496.5 | ALogp: | 3.0 |
| HBD: | 3 | HBA: | 8 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 138.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 36 | QED Weighted: | 0.163 |
| Caco-2 Permeability: | -4.954 | MDCK Permeability: | 0.00007330 |
| Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.051 |
| Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.001 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.903 | Plasma Protein Binding (PPB): | 85.15% |
| Volume Distribution (VD): | 1.089 | Fu: | 8.99% |
| CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.197 |
| CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.743 |
| CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.033 |
| CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.044 |
| CYP3A4-inhibitor: | 0.901 | CYP3A4-substrate: | 0.913 |
| Clearance (CL): | 6.167 | Half-life (T1/2): | 0.414 |
| hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.105 |
| Drug-inuced Liver Injury (DILI): | 0.592 | AMES Toxicity: | 0.039 |
| Rat Oral Acute Toxicity: | 0.681 | Maximum Recommended Daily Dose: | 0.927 |
| Skin Sensitization: | 0.654 | Carcinogencity: | 0.747 |
| Eye Corrosion: | 0.615 | Eye Irritation: | 0.137 |
| Respiratory Toxicity: | 0.953 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003579 | ![]() |
0.776 | D0FG6M | ![]() |
0.224 | ||
| ENC004085 | ![]() |
0.667 | D0J2NK | ![]() |
0.215 | ||
| ENC003128 | ![]() |
0.583 | D0E9KA | ![]() |
0.212 | ||
| ENC003500 | ![]() |
0.532 | D05QDC | ![]() |
0.205 | ||
| ENC004086 | ![]() |
0.508 | D0G3PI | ![]() |
0.203 | ||
| ENC003709 | ![]() |
0.477 | D02DGU | ![]() |
0.203 | ||
| ENC005987 | ![]() |
0.447 | D00DKK | ![]() |
0.203 | ||
| ENC004472 | ![]() |
0.447 | D08NQZ | ![]() |
0.201 | ||
| ENC002144 | ![]() |
0.444 | D0R6RC | ![]() |
0.199 | ||
| ENC003887 | ![]() |
0.440 | D02GAC | ![]() |
0.191 | ||